These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19647276)

  • 41. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the Portuguese Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY) in Brazil.
    Moorthy LN; Saad-Magalhães C; Sato JO; Len CA; Vasco MB; Appenzeller S; Marini R; Oliveira SK; Rodrigues M; Sztajnbok F; Almeida RG; Jesus AA; Campos LM; Silva CA; Peterson MG; Hassett AL; Weiss E; Verma S; Dahodwala MQ; Lehman TJ
    Lupus; 2013 Feb; 22(2):190-7. PubMed ID: 23257403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-cultural adaptation and validation of Systemic Lupus Erythematosus Quality of Life questionnaire into Arabic.
    Aziz MM; Galal MAA; Elzohri MH; El-Nouby F; Leong KP
    Lupus; 2018 Apr; 27(5):780-787. PubMed ID: 29308728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creation and Validation of the European Portuguese Version of the Systemic Lupus Erythematous Quality of Life Questionnaire.
    Ferreira PL; Cunha RN; Macieira C; Fontes T; Inês LS; Maduro A; Martins A; Rajão F; Furtado C; Barcelos A
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines.
    Navarra SV; Tanangunan RM; Mikolaitis-Preuss RA; Kosinski M; Block JA; Jolly M
    Lupus; 2013 Mar; 22(3):262-7. PubMed ID: 23340995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.
    Hosseini N; Bonakdar ZS; Gholamrezaei A; Mirbagher L
    Int J Rheumatol; 2014; 2014():151530. PubMed ID: 25313310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population.
    Catoggio C; Martínez Muñoz A; Chaparro Del Moral R; Klajn DS; Papasidero SB; Machado Escobar MA; Gonzalez Lucero L; Lucero E; Martinez L; Muñoz SA; Collado MV; Gomez GN; Sarano J; Marin J; Scolnik M; Romero J; Barreira JC; Zalazar MM; Rillo OL; Pisoni C
    Lupus; 2021 Dec; 30(14):2230-2236. PubMed ID: 34894851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of health-related family role functioning in systemic lupus erythematosus: preliminary validation of a new measure.
    Hassett AL; Li T; Radvanski DC; Savage SV; Buyske S; Schiff SA; Katz PP
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1341-8. PubMed ID: 22438284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease-specific patient reported outcome tools for systemic lupus erythematosus.
    Jolly M; Pickard AS; Block JA; Kumar RB; Mikolaitis RA; Wilke CT; Rodby RA; Fogg L; Sequeira W; Utset TO; Cash TF; Moldovan I; Katsaros E; Nicassio P; Ishimori ML; Kosinsky M; Merrill JT; Weisman MH; Wallace DJ
    Semin Arthritis Rheum; 2012 Aug; 42(1):56-65. PubMed ID: 22480408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese.
    Kong KO; Ho HJ; Howe HS; Thong BY; Lian TY; Chng HH; Leong KP;
    Arthritis Rheum; 2007 Aug; 57(6):980-5. PubMed ID: 17665463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and validation of LupusCol, an instrument for the evaluation of health-related quality of life in Colombian adult patients with systemic lupus erythematosus.
    Quintana López G; Muñetón López G; Coral-Alvarado P; Méndez Patarroyo P; Molina J; Chalem P; Díaz J
    Rheumatology (Oxford); 2015 Jan; 54(1):104-12. PubMed ID: 25099768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
    Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
    Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore.
    Thumboo J; Fong KY; Ng TP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jan; 26(1):97-102. PubMed ID: 9918248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus.
    Mok CC; Kosinski M; Ho LY; Chan KL; Jolly M
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):297-304. PubMed ID: 25156199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibromyalgia is a major contributor to quality of life in lupus.
    Gladman DD; Urowitz MB; Gough J; MacKinnon A
    J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.